Results 121 to 130 of about 77,790 (265)

Cannabis Indica [PDF]

BMJ, 1883
openaire   +2 more sources

For and Against: Cannabis [PDF]

Psychiatrische Praxis, 2005
Michael, Schaub, Kenneth, Dürsteler-MacFarland, Rudolf, Stohler, Rainer, Thomasius   +3 more
openaire   +2 more sources

Varenicline for cannabis use disorder: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark, Kevin M. Gray, Nathaniel L. Baker, Brian J. Sherman, Bryan Tolliver, Jessica Burt, Alonzo Steplight, Elizabeth Chapman, Amanda Wagner   +8 more
wiley   +1 more source

Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling

Addiction, Volume 120, Issue 4, Page 686-687, April 2025.
Rachel Lees Thorne, Tom P. Freeman
wiley   +1 more source

Does the total consumption model apply to cannabis use?

Addiction, EarlyView.
Abstract Aims To test whether the total consumption model and its extension, the theory of collectivity, apply to adolescent cannabis use. We estimated: (1) whether the distribution of cannabis use frequency was stable over time; (2) whether changes in average cannabis use were mirrored across consumption quantiles; and (3) whether higher average use ...
Thor Norström, Håkan Leifman
wiley   +1 more source

Who is at risk? Core mental health symptoms and problematic cannabis use in Germany. [PDF]

J Cannabis Res
Krowartz EM, Schwarzkopf L, Olderbak S, Klug SJ, Koller G, Neumeier E, de Matos EG, Hoch E.   +7 more
europepmc   +1 more source

Cannabis dispensary exposure and smoked, vaped and edible cannabis use among young adults: Comparison of web‐scraped and government‐maintained registries

Addiction, EarlyView.
Abstract Background and aims The impact of exposure to cannabis dispensaries on young adult cannabis use may depend on how exposures and outcomes are defined. We estimated associations of dispensary exposure with young adult cannabis use across: (a) a government‐maintained licensed dispensaries registry versus a web‐scraped list of licensed and ...
Alyssa F. Harlow, Michael P. Williams, Rosalie Liccardo Pacula, Adam M. Leventhal, Eric R. Pedersen, Myles G. Cockburn, Laura K. Thompson, Junhan Cho, Jessica L. Barrington‐Trimis, Danielle F. Haley   +9 more
wiley   +1 more source

Local availability of cannabis retail outlets on parents' cannabis use, acceptability, and perceived addictiveness: A longitudinal study in Washington State. [PDF]

PLoS One
Le VT, Bailey JA, Epstein M, Dunbar MD, Satchell AK, Pandika DM.   +5 more
europepmc   +1 more source

The prevalence of cannabidiol (CBD) use in North America and Europe: A meta‐analysis

Addiction, EarlyView.
Abstract Background and aims The global cannabidiol (CBD) market has expanded in recent years. Several studies suggest CBD use, whether for medical or recreational purposes, is on the rise; however, no systematic assessments of its prevalence have been conducted so far. This meta‐analysis aimed to estimate the prevalence of CBD use in North America and
Sara Weidberg, Clara Iza‐Fernández, Layla Alemán‐Moussa, Andrea Krotter, Alba González‐Roz   +4 more
wiley   +1 more source

Cannabis Effects on Neurocognition and HIV-Related Outcomes: Protocol for a Longitudinal Observational Cohort Study. [PDF]

JMIR Res Protoc
Matthews I, Wilson A, Durrell M, Remund Wiger E, Hotton A, Rower JE, Livne O, Gonzalez R, Duncan DT, Manuzak J, Schumm P, Carrico A, Demarco C, Almirol E, Kondic L, Toscano I, DeBrosse J, Keedy S, Schneider JA, Knox J.   +19 more
europepmc   +1 more source